Don’t Stop Me Now: Management of Medication-Assisted Treatment in Hospitalized Patients
Rochester, NY US
May 7, 2020
This activity will provide a review of MAT medications and inpatient management of patients on MAT. Information provided will include generalized management of MAT medications during a hospitalization, management of acute pain, and peri-procedural management including various pharmacological therapies. After participating in this activity, pharmacist should have a better understanding of how certain medications work for MAT and how to approach the management of these patients.
Target Audience
- Pharmacists
Learning Objectives
- Compare and contrast the different pharmacological features of buprenorphine, methadone, and naltrexone
- Discuss the evidence for continuing Medication-Assisted Treatment (MAT) in hospitalized patients
- Describe pain management options in patients receiving MAT
- Review microinduction of buprenorphine using a patient case
Additional Information
Attachment | Size |
---|---|
![]() | 23.3 KB |
![]() | 122.9 KB |
University of Rochester Medical Center
601 Elmwood Ave.
Rochester, NY
14642
United States
Relevant financial relationships: Planning committee members and the presenter have nothing to disclose
The presenter will discuss off-label use of drugs
Planning committee members
Linda Thomas, PharmD, BCPS
Residency Coordinator
University of Rochester Medical Center
Rachel Schult, PharmD, DABAT
Toxicology Clinical Pharmacy Specialist
University of Rochester Medical Center
Course reviewer
James Lichauer, PharmD, BCPS, FASHP
PI Program Director, Pharmacy
Vizient
Presenter
Raquel Roberts, PharmD
PGY1 Pharmacy Resident
University of Rochester Medical Center

Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and University of Rochester Medical Center. Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
___________________________________________
Designation Statements:
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-20-087-L01-P
CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).
Available Credit
- 1.00 ACPE Pharmacist